The pharmaceutical industry is increasingly using artificial intelligence (AI) to revolutionize drug discovery.

AI-specializing start-ups and biotechs are employing the technology to design and develop new medicines.

Major pharmaceutical companies are partnering with AI-focused start-ups and biotechs for cost reduction and faster processes.

AI is being used in aging research and cancer drug development, promoting personalized treatment and speeding up discovery.

Despite challenges and skepticism, AI's integration into the life sciences sector holds significant potential to transform the field.